A tumor targeted mesoporous silica nanoparticles (MSN)-based drug delivery system (DDS)
was developed for inhalation treatment of lung cancer. The system was capable of …

Lung cancer is the most common cause of cancer mortality in male and female patients in
the US. The etiology of non-small cell lung cancer (NSCLC) is not fully defined, but new data …

Background: Survivorship concerns for patients with lung and bronchus cancers include
quality of life and physical and psychological aspects. Recommendations for follow-up care …

The aim of this study was to investigate the relationship between standardised uptake value
(SUV) obtained from [18F] fluorodeoxyglucose positron emission tomography (FDG PET) …

Accumulating evidence has indicated that long non-coding RNA PVT1 is upregulated in
various human cancers. However, it remains unclear whether PVT1 is involved in the …

Purpose: To evaluate the changes in pulmonary function after high-dose radiotherapy (RT)
for non-small-cell lung cancer in patients with a long-term disease-free survival. Methods …

Autoantibodies against tumor antigens are promising means for cancer diagnosis and
prognosis. In this study, we applied a proteomic approach to identify proteins that commonly …

Purpose: Some 85% of lung cancers are smoking related. Here, we investigate the role of
serine protease HtrA3 in smoking-related lung cancer. Experimental Design: We assess …

Objectives Several treatment modalities are available for patients with stage I non-small cell
lung cancer (NSCLC). Over the past decade, these treatment modalities have been further …

PURPOSE: To evaluate the efficacy of dose-individualized stereotactic body radiotherapy
(SBRT) and adjuvant chemotherapy in stage T1–3N0M0 non-small cell lung cancer …